A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
7 Hills Pharma, LLC
7 Hills Pharma, LLC
Radiopharm Theranostics, Ltd
Replimune Inc.
ImmunityBio, Inc.
University of Pittsburgh
Medicenna Therapeutics, Inc.
M.D. Anderson Cancer Center
Shattuck Labs, Inc.
Molecular Templates, Inc.
Institut Bergonié
Incyte Corporation